What is the main business of RABO?

The main business activity of RABO focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 29, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Dominikańska 9, 87-100 Toruń.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $66,628 in 2025.

Yes, the company recorded a net profit of $14,003 in 2025.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $45,272 in 2025, representing 89% of all operating expenses.

RABOsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-11-29

Share capital

5,000.00 PLN

Registered address

ul. Dominikańska 9, 87-100 Toruń, Poland

Electronic delivery address

AE:PL-60907-86210-ERAAG-29

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 73 days late).

202512/03/2026
202430/06/2025
202331/01/2024
202215/02/2023
202126/09/2022
202012/04/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 66.63kMedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD 14.00kMedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 51.12kMedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 51.69kMedianUSD 883.09kAverageUSD 31.39m

Industry

Authorized Representatives

Paweł Boś – Management Board Member

Tomasz Jakub Rączka – President of the Management Board

Manner of representation

To make declarations and sign on behalf of the company, each member of the management board is authorized individually.

Ownership

Owner	Shares	Share value	Stake
Paweł Bośage 43	50	$675.31	50%
Tomasz Jakub Rączkaage 40	50	$675.31	50%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-07-01.

mBank
89 1140 2004 0000 3302 7979 8897

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 8, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Torunia

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
DR Andresp. z o.o.	$453,987.42	drandre.pl
Ti-Comsp. z o.o.	$157,549.77	ticomglobal.com
LideoS.A.	$95,067.91	lideo.tech
Munar PharmaS.A.	$85,649.72	munar.pl
BIO Animalisp. z o.o.	$49,176.96	proanimali.com
Ampliconsp. z o.o.	$48,330.99	amplicon.pl
Xenira Pharmaceuticalssp. z o.o.	$26,670.82	xenirapharma.com
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com